Specificity: A717 specifically recognizes Amadori-modified glycated albumin. It does not react with non-glycated albumin, free glucose, or other glycated/non-glycated proteins. The epitope is deoxyfructosyllysine in the Amadori configuration. This clone also cross-reacts with mouse glycated albumin.
Isotype: Mouse IgG
Tested species reactivity: Human, Mouse
Clonality: Monoclonal
Summary
Specifications
Antibody Isotype
IgG
Clone
A717
Species Reactivity
Human
Immunogen
The original antibody was obtained by immunizing mice with native glycated albumin
Conjugate
Unconjugated
Applications
Application Notes
ELISA, WB Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
General Notes
This monoclonal IgG antibody (DMABD-JX280, Hi-Puri™ Mouse Anti-Human Glycated Albumin monoclonal antibody, Clone A717) is highly specific for human glycated albumin, specifically recognizing the Amadori-modified configuration with the deoxyfructosyllysine epitope. Demonstrating exceptional selectivity, it exhibits no cross-reactivity with non-glycated albumin, free glucose, or other glycated and non-glycated proteins, while notably showing cross-reactivity with mouse glycated albumin. Validated for use in ELISA and neutralization assays (Neut), this high-performance clone serves as an ideal tool for targeted glycation research and diagnostic development.
Target
Alternative Names
Glycated Albumin
Citations
Publication ()
Have you cited DMABD-JX280 in a publication? Let us know and earn a reward for your research.
My Review for Hi-Puri™ Mouse Anti-Human Glycated Albumin monoclonal antibody, clone A717
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Publication 
Loading ......
